← Leaderboards
William E Gillanders
Washington University
$14,751,159
Attributed
$21,257,948
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,910,454 · 10
By mechanism
U2C$14,923,888 · 2
T32$7,393,976 · 1
R01$4,681,371 · 3
P50$3,236,489 · 3
K23$674,730 · 1
Top collaborators
- Timothy J Eberlein13 shared
- Graham A Colditz9 shared
- Li Ding6 shared
- Ryan C Fields6 shared
- Samuel Achilefu5 shared
- Robert David Schreiber5 shared
- Adetunji T Toriola4 shared
Most similar at Washington University
Same institution · by research overlap
- Yongjian Liu$10,408,809
- Robert David Schreiber$32,299,425
- Samuel Klein$33,055,933
- William G Hawkins$8,815,633
- Adam S Kibel$9,755,501
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsUniversitiesWashingtonTranslational ResearchResponseResearch PersonnelTumorBasePhenotypeSamplingBasic ScienceMolecularCollaborationsTissuesCellsMalignant Neoplasm Of PancreasSingle-Cell Rna SequencingTriple-Negative Invasive Breast CarcinomaNeoplasm MetastasisNeoplastic CellNew TechnologyDesignMalignant Breast NeoplasmImmune
Grant awards (55)
Surgical Oncology Basic Science and Translational Research Training Program$624,527
T32 · FY2025 · CA · contact PI
Career Enhancement Program$189,787
P50 · FY2025 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$616,670
T32 · FY2024 · CA · contact PI
Career Enhancement Program$182,195
P50 · FY2024 · CA · contact PI
WASHINGTON UNIVERSITY HUMAN TUMOR ATLAS RESEARCH CENTER$874,677
U2C · FY2023 · CA
Surgical Oncology Basic Science and Translational Research Training Program.$715,584
T32 · FY2023 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$625,110
R01 · FY2023 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$349,813
U2C · FY2023 · CA · contact PI
Career Enhancement Program$179,655
P50 · FY2023 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,767,704
U2C · FY2022 · CA
Molecular, Cellular, and Tissue Characterization Unit$979,965
U2C · FY2022 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program.$676,820
T32 · FY2022 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$625,095
R01 · FY2022 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,771,877
U2C · FY2021 · CA
Molecular, Cellular, and Tissue Characterization Unit$988,750
U2C · FY2021 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$637,864
R01 · FY2021 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program.$629,591
T32 · FY2021 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,771,881
U2C · FY2020 · CA
Molecular, Cellular, and Tissue Characterization Unit$992,570
U2C · FY2020 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program.$652,646
T32 · FY2020 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$637,836
R01 · FY2020 · CA · contact PI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine$410,431
P50 · FY2020 · CA · contact PI
Career Enhancement Program$94,583
P50 · FY2020 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,714,176
U2C · FY2019 · CA
Molecular, Cellular, and Tissue Characterization Unit$964,136
U2C · FY2019 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$629,038
R01 · FY2019 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program.$627,511
T32 · FY2019 · CA · contact PI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine$382,343
P50 · FY2019 · CA · contact PI
Career Enhancement Program$88,769
P50 · FY2019 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,752,191
U2C · FY2018 · CA
Molecular, Cellular, and Tissue Characterization Unit$996,148
U2C · FY2018 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$559,406
T32 · FY2018 · CA · contact PI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine$503,987
P50 · FY2018 · CA · contact PI
Career Enhancement Program$99,483
P50 · FY2018 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$591,993
T32 · FY2017 · CA · contact PI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine$464,275
P50 · FY2017 · CA · contact PI
Career Enhancement Program$79,999
P50 · FY2017 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$1,791
T32 · FY2017 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$580,549
T32 · FY2016 · CA · contact PI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine$489,305
P50 · FY2016 · CA · contact PI
Career Enhancement Program$71,677
P50 · FY2016 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$565,494
T32 · FY2015 · CA · contact PI
Surgical Oncology Basic Science and Translational Research Training Program$551,394
T32 · FY2014 · CA · contact PI
SCT PROBES FOR PATHOGEN IMMUNITY$376,200
R01 · FY2014 · AI · contact PI
Peripheral Blood Molecular Staging of Breast Cancer$234,822
R01 · FY2010 · CA · contact PI
Peripheral Blood Molecular Staging of Breast Cancer$234,850
R01 · FY2009 · CA · contact PI
Peripheral Blood Molecular Staging of Breast Cancer$234,876
R01 · FY2008 · CA · contact PI
Peripheral Blood Molecular Staging of Breast Cancer$210,575
R01 · FY2007 · CA · contact PI
Peripheral Blood Molecular Staging of Breast Cancer$235,105
R01 · FY2006 · CA · contact PI
Molecular detection of breast cancer in peripheral blood$134,946
K23 · FY2006 · CA · contact PI
Molecular detection of breast cancer in peripheral blood$134,946
K23 · FY2005 · CA
Molecular detection of breast cancer in peripheral blood$112,290
K23 · FY2004 · CA
Molecular detection of breast cancer in peripheral blood$22,656
K23 · FY2004 · CA
Molecular detection of breast cancer in peripheral blood$134,946
K23 · FY2003 · CA
Molecular detection of breast cancer in peripheral blood$134,946
K23 · FY2002 · CA